These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 7602073

  • 1. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis.
    Caselmann WH.
    J Hepatol; 1995; 22(1 Suppl):34-7. PubMed ID: 7602073
    [Abstract] [Full Text] [Related]

  • 2. Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators.
    Schlüter V, Meyer M, Hofschneider PH, Koshy R, Caselmann WH.
    Oncogene; 1994 Nov; 9(11):3335-44. PubMed ID: 7936659
    [Abstract] [Full Text] [Related]

  • 3. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
    Kim DG.
    Methods Mol Biol; 2006 Nov; 317():141-55. PubMed ID: 16264227
    [Abstract] [Full Text] [Related]

  • 4. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation.
    Lauer U, Weiss L, Lipp M, Hofschneider PH, Kekulé AS.
    Hepatology; 1994 Jan; 19(1):23-31. PubMed ID: 8276360
    [Abstract] [Full Text] [Related]

  • 5. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY, Park E, Park JH, Park DH, Moon WS, Cho BH, Shin HS, Kim DG.
    Oncogene; 2001 Jul 27; 20(33):4568-75. PubMed ID: 11494152
    [Abstract] [Full Text] [Related]

  • 6. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
    Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C, Kremsdorf D.
    Cancer Res; 2001 Nov 01; 61(21):7803-10. PubMed ID: 11691796
    [Abstract] [Full Text] [Related]

  • 7. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.
    Chen WN, Oon CJ, Leong AL, Koh S, Teng SW.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):885-92. PubMed ID: 11027564
    [Abstract] [Full Text] [Related]

  • 8. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector].
    Joo HY, Han KH, Ryu WS.
    Taehan Kan Hakhoe Chi; 2002 Dec 05; 8(4):371-80. PubMed ID: 12506241
    [Abstract] [Full Text] [Related]

  • 9. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z, Zhang Y, Gu W, Wang Z, Li D, Zhang F, Qiu G, Xie K.
    Int J Oncol; 2005 Feb 05; 26(2):467-73. PubMed ID: 15645132
    [Abstract] [Full Text] [Related]

  • 10. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
    Tu H, Gao HF, Ma GH, Liu Y.
    Zhonghua Yi Xue Za Zhi; 2006 May 16; 86(18):1249-52. PubMed ID: 16796883
    [Abstract] [Full Text] [Related]

  • 11. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator.
    Kekulé AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R.
    Nature; 1990 Feb 01; 343(6257):457-61. PubMed ID: 2153938
    [Abstract] [Full Text] [Related]

  • 12. HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.
    Shamay M, Agami R, Shaul Y.
    Oncogene; 2001 Oct 18; 20(47):6811-9. PubMed ID: 11687960
    [Abstract] [Full Text] [Related]

  • 13. Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro.
    Luber B, Arnold N, Stürzl M, Höhne M, Schirmacher P, Lauer U, Wienberg J, Hofschneider PH, Kekulé AS.
    Oncogene; 1996 Apr 18; 12(8):1597-608. PubMed ID: 8622879
    [Abstract] [Full Text] [Related]

  • 14. [Trans-activating function of integrated hepatitis B virus].
    Nakatake H, Yamamoto S, Matsubara K.
    Nihon Rinsho; 1993 Feb 18; 51(2):357-63. PubMed ID: 8385237
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus and hepatocellular carcinoma: a possible role for the viral transactivators.
    Levrero M, Balsano C, Avantaggiati ML, Natoli G, De Marzio E, Will H.
    Ital J Gastroenterol; 1991 Dec 18; 23(9):576-83. PubMed ID: 1662093
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
    Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C, Harris CC.
    Oncogene; 2001 Jun 21; 20(28):3620-8. PubMed ID: 11439325
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
    Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Bréchot C.
    Oncogene; 1999 Aug 26; 18(34):4848-59. PubMed ID: 10490818
    [Abstract] [Full Text] [Related]

  • 18. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
    Yeh CT, Shen CH, Tai DI, Chu CM, Liaw YF.
    Oncogene; 2000 Nov 02; 19(46):5213-20. PubMed ID: 11077437
    [Abstract] [Full Text] [Related]

  • 19. [Gene expression of hepatitis viruses in the liver and hepatocarcinogenesis].
    Koike K.
    Hum Cell; 1992 Jun 02; 5(2):150-9. PubMed ID: 1327091
    [Abstract] [Full Text] [Related]

  • 20. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
    Lee YI, Lee S, Lee Y, Bong YS, Hyun SW, Yoo YD, Kim SJ, Kim YW, Poo HR.
    Oncogene; 1998 May 07; 16(18):2367-80. PubMed ID: 9620554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.